Prevalence of Joint Hypermobility and Patterns of Articular Manifestations in Patients with Inflammatory Bowel Disease

Table 4

Medication of IBD patients in relation to Joint Hypermobility. A number of patients were on combination treatment (data not shown).

Treatment	Crohn’s disease N	Ulcerative colitis N
	(JH/Non-JH)	(JH/Non-JH)
Steroids the last year	17 (10/7)	11 (3/8)
Aminosalycilates	19 (12/7)	20 (7/13)
Azathioprine	14 (11/3)	7 (2/5)
Anti-TNF	12 (10/2)	0
Antibiotics	5 (3/2)	2 (1/1)
Methotrexate	1 (1/0)	1 (0/1)
Mercaptopourin	1 (0/1)	1 (0/1)